Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein
about
GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System FunctionCortical phosphorylated α-Synuclein levels correlate with brain wave spectra in Parkinson's diseaseRepurposing the NRF2 Activator Dimethyl Fumarate as Therapy Against Synucleinopathy in Parkinson's DiseaseMicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.Caloric Restriction Protects against Lactacystin-Induced Degeneration of Dopamine Neurons Independent of the Ghrelin Receptor.Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.The Proteasome Inhibition Model of Parkinson's Disease.Treatments and compositions targeting α-synuclein: a patent review (2010-2016).How does conserved dopamine neurotrophic factor protect against and rescue neurodegeneration of PC12 cells?Parkinson's disease: experimental models and reality.An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition.Parkinson's disease: towards better preclinical models and personalized treatments.Ketamine Does Not Exert Protective Properties on Dopaminergic Neurons in the Lactacystin Mouse Model of Parkinson's DiseaseLongitudinal monoaminergic PET imaging of chronic proteasome inhibition in minipigsThe Protective Effect of Repeated 1MeTIQ Administration on the Lactacystin-Induced Impairment of Dopamine Release and Decline in TH Level in the Rat Brain
P2860
Q27309907-BE10AA64-46D9-4519-B09F-9C3D07F6C793Q37062735-1C1DFC80-5E81-417C-9BD6-B606AE3A1BCEQ37091371-ACA81B7F-47F6-444D-AAFA-A3CBB8509E59Q37702119-F7A26E9A-FCB9-4794-B1E2-903FA078997DQ37729142-0312F202-6801-43A2-B7F0-3DC78D8353B6Q38821744-A619D851-EC39-48B0-AFA0-DF7895B06407Q38996038-1C1059A4-11FB-4463-A53D-191C458D1338Q39007523-B9F0B9B2-6328-4095-AEA8-182DB4F3314CQ41429895-83E6A25E-F2B3-4B25-9EA7-7D93FB0CA1C8Q47389506-0C3FD104-C991-46B7-A8D5-9E6591A2400AQ48171351-79E59B70-0504-49DA-8721-B813F13C36A9Q50536122-980129EA-9599-48FD-9AC4-DB21BEC46D23Q57072471-979929FD-8ABC-4017-A874-F9CF84DB5416Q57794605-D5819582-2342-4760-B9E4-D37320E6D231Q58733097-D1D5478E-4C68-40C2-9C9D-62C5A83FE596
P2860
Nigral proteasome inhibition in mice leads to motor and non-motor deficits and increased expression of Ser129 phosphorylated α-synuclein
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Nigral proteasome inhibition i ...... 129 phosphorylated α-synuclein
@ast
Nigral proteasome inhibition i ...... 129 phosphorylated α-synuclein
@en
type
label
Nigral proteasome inhibition i ...... 129 phosphorylated α-synuclein
@ast
Nigral proteasome inhibition i ...... 129 phosphorylated α-synuclein
@en
prefLabel
Nigral proteasome inhibition i ...... 129 phosphorylated α-synuclein
@ast
Nigral proteasome inhibition i ...... 129 phosphorylated α-synuclein
@en
P2093
P2860
P50
P356
P1476
Nigral proteasome inhibition i ...... 129 phosphorylated α-synuclein
@en
P2093
Anissa El Arfani
Anke Van der Perren
Ellen Merckx
Joeri Van Liefferinge
Thomas Demuyser
Veerle Baekelandt
Yvette Michotte
P2860
P356
10.3389/FNBEH.2015.00068
P577
2015-03-31T00:00:00Z